ORC1 and diffuse large B-cell lymphoma: Interestingly, a similar proliferation inhibitory effect was observed in ORC1 shRNA and combination treatment, which indicates that ORC1 expression was essential for DLBCL tumor cells and suppression of ORC1 in DNA replication process may contribute to the synergistic anti-tumor effect after co-administration of SHR2554 and HBI8000.